<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Several reports of few or single cases have also documented sustained improvement after DBS in PD caused by different 
 <italic>LRRK2</italic> mutations (Table 
 <xref rid="Tab1" ref-type="table">1</xref>), with follow-up up to eight years.
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>,
  <xref ref-type="bibr" rid="CR33">33</xref>
 </sup> A few report a beneficial effect, but highlight challenges in managing dystonia or dyskinesias postoperatively.
 <sup>
  <xref ref-type="bibr" rid="CR34">34</xref>,
  <xref ref-type="bibr" rid="CR35">35</xref>
 </sup> A comprehensive 2008 assessment of 
 <italic>LRRK2</italic>-positive PD identified 12 DBS cases and descriptively reported good or excellent clinical outcome in eight of the patients, moderate in two and poor outcome in the last two patients.
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup> In a single case report of a 
 <italic>LRRK2</italic> N1437H-carrier with significant psychiatric comorbidity, bradykinesia, rigidity and dystonia deteriorated a few weeks postoperatively and the patient committed suicide six months after the surgery.
 <sup>
  <xref ref-type="bibr" rid="CR36">36</xref>
 </sup>
</p>
